Works matching AU Bassil, A. K.


Results: 8
    1
    2
    3
    4
    5

    Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia.

    Published in:
    British Journal of Clinical Pharmacology, 2022, v. 88, n. 12, p. 5238, doi. 10.1111/bcp.15428
    By:
    • Furze, Rebecca C.;
    • Molnar, Judit;
    • Parr, Nigel J.;
    • Ahmad, Faiz;
    • Henry, Yvette;
    • Howe, David;
    • Singh, Rajendra;
    • Toal, Martin;
    • Bassil, Anna K.;
    • Bernard, Sharon G.;
    • Davis, Robert P.;
    • Gibson, Adele;
    • Maller, N. Claire;
    • Sharp, Catriona;
    • Tough, David F.;
    • Prinjha, Rab K.;
    • Lewis, Huw D.
    Publication type:
    Article
    6
    7
    8